Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
GLYCOMIMETICS INC | Director | Common Stock | 515K | $1.55M | $3.00 | Mar 29, 2024 | Direct |
NOVAVAX INC | Director | Common Stock | 18.9K | $263K | $13.90 | Jun 12, 2024 | Direct |
NOVAVAX INC | Director | Stock Option (Right to Buy) | 15.6K | $248K | $15.86 | Jun 12, 2024 | Direct |
NOVAVAX INC | Director | Restricted Stock Units | 10.4K | $145K | $13.90 | Jun 12, 2024 | Direct |
GLYCOMIMETICS INC | Director | Stock Option (right to buy) | 40K | May 1, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
NVAX | NOVAVAX INC | Jun 12, 2024 | 4 | $248K | 4 | Jun 14, 2024 | Director |
GLYC | GLYCOMIMETICS INC | May 1, 2024 | 1 | $0 | 4 | May 1, 2024 | Director |
GLYC | GLYCOMIMETICS INC | Dec 29, 2023 | 1 | $10K | 4 | Jan 2, 2024 | Director |
GLYC | GLYCOMIMETICS INC | Sep 30, 2023 | 1 | $10K | 4 | Oct 3, 2023 | Director |
NVAX | NOVAVAX INC | Jun 10, 2023 | 4 | $0 | 4 | Jun 13, 2023 | Director |
GLYC | GLYCOMIMETICS INC | May 19, 2023 | 1 | $0 | 4 | May 22, 2023 | Director |
GLYC | GLYCOMIMETICS INC | Mar 29, 2023 | 1 | $10K | 4 | Apr 2, 2024 | Director |
GLYC | GLYCOMIMETICS INC | Dec 31, 2022 | 2 | $0 | 5 | Feb 6, 2023 | Director |
NVAX | NOVAVAX INC | Jun 17, 2022 | 2 | $0 | 4 | Jun 21, 2022 | Director |
NVAX | NOVAVAX INC | Jun 10, 2022 | 2 | $0 | 4 | Jun 14, 2022 | Director |
GLYC | GLYCOMIMETICS INC | May 18, 2022 | 1 | $0 | 4 | May 20, 2022 | Director |
NVAX | NOVAVAX INC | Jun 25, 2021 | 2 | $0 | 4/A | Aug 20, 2021 | Director |
NVAX | NOVAVAX INC | Jun 17, 2021 | 2 | $0 | 4 | Jun 22, 2021 | Director |
NVAX | NOVAVAX INC | May 19, 2021 | 1 | $97.7K | 4 | May 21, 2021 | Director |